spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Searching News Database:  Paradigm 


 Your search returned too many results! The most recent 500 items are shown below:
 HSMN NewsFeed - 2 Jul 2026
Spinogenix Appoints Professor Joseph T. Coyle, MD, Current Chair of Psychiatry and Neuroscience at Harvard Medical School, to Scientific Advisory Board
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 Jun 2026
CereVasc, Inc. Completes Enrollment in STRIDE Pivotal Trial of the eShunt(R) System
Devices Neurosurgery
 HSMN NewsFeed - 15 Jun 2026
Celltaxis Names Co-Founder Eileen Heffernan as CEO to Accelerate Growth and Expand Leadership in Lymphatic Disease Therapeutics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 May 2026
CREATE Medicines Announces $122 Million Series B Financing to Advance In Vivo CAR Pipeline in Autoimmune Disease and Oncology
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 17 Apr 2026
Corify Care Receives FDA Clearance for ACORYS(R) -- Introducing Instant, 4-D Electroanatomical Cardiac Mapping in Real-time
Devices Cardiology FDA
 HSMN NewsFeed - 14 Apr 2026
Aegis Ventures and Wavelet Medical Aim to Redefine the Standard of Care in Fetal Medicine
Devices Neurology Monitoring Venture Capital
 HSMN NewsFeed - 10 Apr 2026
Vivatides Therapeutics Announces Oversubscribed $54 Million Series A Financing to Accelerate Extrahepatic RNA Therapeutics Development
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Mar 2026
Otsuka Pharmaceutical to Acquire Transcend Therapeutics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 26 Mar 2026
Pinnacle Medicines, a Pioneer of Oral Peptide Therapeutics, Announces Oversubscribed $89 Million Series B Financing to Advance Pipeline into Clinical Trials
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Mar 2026
Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 9 Mar 2026
Baird Medical Accelerates U.S. Expansion in Interventional Thyroidology at NASIT 2026
Devices Interventional
 HSMN NewsFeed - 3 Feb 2026
Industry Veteran and Med Tech Pioneer Appointed Special Advisor to ProVerum
Devices Urology Personnel
 HSMN NewsFeed - 14 Jan 2026
GT Medical Technologies Announces First Patients Treated with GammaTile in the BRIDGES Trial for Newly Diagnosed Glioblastoma
Devices Neurosurgery Oncology
 HSMN NewsFeed - 12 Jan 2026
Neurolief receives FDA PMA Approval for First At-Home Brain Neuromodulation Therapy for Adults Whose Depression Was Not Adequately Improved by Antidepressants
Devices Neurology FDA
 HSMN NewsFeed - 4 Nov 2025
Ratio Therapeutics Announces the Appointment of Marcel Reichen as Chief Strategy Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Oct 2025
Hemab Therapeutics Announces $157 Million Series C Financing to Advance Next-Generation Treatments for Underserved Bleeding Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Oct 2025
Lumen Bioscience Expands Board and Leadership Team to Advance Clinical Pipeline of Novel Oral Biologics
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Aug 2025
Precigen Announces Full FDA Approval of PAPZIMEOS (zopapogene imadenovec-drba), the First and Only Approved Therapy for the Treatment of Adults with Recurrent Respiratory Papillomatosis
Biopharmaceuticals FDA
 HSMN NewsFeed - 29 Jul 2025
Leo Cancer Care Receives FDA 510(k) Clearance for Marie(R) - A Revolutionary Upright Radiotherapy Platform
Devices Oncology FDA
 HSMN NewsFeed - 30 Jun 2025
NewLines(TM) App Update Extends AI-Assisted SmartProfiles(TM) to the Android Platform
Devices Biopharmaceuticals Diagnostics Distribution
 HSMN NewsFeed - 18 Jun 2025
Neurvati Neurosciences and GRIN Therapeutics Announce Appointment of Gail Farfel, PhD to Their Boards of Directors
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 23 May 2025
England's NICE Recommends FILSPARI(R) (sparsentan) as a Treatment Option for IgA Nephropathy
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 12 May 2025
Ted Myles Joins Cellarity as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 May 2025
Spinogenix Announces FDA-Authorized Expanded Access Program for SPG302, the First Synaptic Regenerative Therapy to Treat ALS
Biopharmaceuticals Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 1 Apr 2025
Zimmer Biomet Receives CE Mark Approval for RibFix Advantage(R) Fixation System
Devices Regulatory Orthopaedic
 HSMN NewsFeed - 19 Mar 2025
Terumo Neuro Celebrates 15 Years of the WEB(TM) Device: A Game-Changing Innovation in Aneurysm Treatment
Devices Interventional Neurology
 HSMN NewsFeed - 5 Feb 2025
Newronika Receives Investigational Device Exemption (IDE) from FDA to Initiate U.S. Clinical Trial of Adaptive DBS System
Devices Neurology FDA
 HSMN NewsFeed - 30 Jan 2025
Coeptis Therapeutics Holdings Becomes COEPTIS: Embracing a Future of Technology and Innovation
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Jan 2025
FindReps(R) App Update Features AI-Assisted SmartProfiles(TM)
Devices Biopharmaceuticals Diagnostics Distribution
 HSMN NewsFeed - 26 Dec 2024
Coeptis Therapeutics Makes Bold Strides in Innovation with the Acquisition of NexGenAI Affiliates Network Platform and Launch of Coeptis Technologies
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 22 Oct 2024
AvenCell Raises $112 Million in Series B; Funding Led by Novo Holdings
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Oct 2024
X-Bolt Announces First U.S. Implant of Pro-X1(R) Trochanteric Nailing System
Devices Orthopaedic Product Launch
 HSMN NewsFeed - 7 Oct 2024
Medinol Announces Successful First-in-Human Implantation of ChampioNIR Drug-Eluting Peripheral Stent System in Australia
Devices Interventional
 HSMN NewsFeed - 27 Sep 2024
Boston Scientific Receives Japanese Regulatory Approval for the FARAPULSE(TM) Pulsed Field Ablation System
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 30 Jul 2024
ViaLase Receives CE Mark for First Femtosecond Laser for the Treatment of Glaucoma, the ViaLase(R) Laser
Devices Ophthalmology Regulatory Distribution
 HSMN NewsFeed - 24 Jul 2024
Beacon Therapeutics Appoints Lance Baldo, MD as Chief Executive Officer and Thomas Biancardi as Chief Financial Officer
Biopharmaceuticals Ophthalmology Personnel
 HSMN NewsFeed - 19 Jun 2024
European Commission grants Sobi(R) Marketing Authorisation for ALTUVOCT(TM) for treatment of haemophilia A
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 9 May 2024
OrthoXel Receives FDA 510(k) Clearance for their Vertex Hip Fracture Nail (HFN)
Devices Orthopaedic FDA
 HSMN NewsFeed - 8 May 2024
4C Medical's AltaValve System Secures Dual FDA Breakthrough Device Designations, Expediting Patient Access to Advanced Mitral Valve Therapies
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 29 Apr 2024
Labcorp Receives FDA Approval for First Companion Diagnostic for Use with Pfizer's Newly Approved Gene Therapy to Treat Patients with Hemophilia B
Biopharmaceuticals Diagnostics FDA
 HSMN NewsFeed - 29 Apr 2024
Repertoire(R) Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases
Biopharmaceuticals
 HSMN NewsFeed - 23 Apr 2024
Flare Therapeutics Appoints Douglas Manion, M.D., FRCP (C) as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 22 Apr 2024
SystImmune, Inc. Appoints Dr. Jie D'Elia as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Mar 2024
Maverix Medical Closes Acquisition of Cirrus Bio as Foundation for Diagnostics Platform in Lung Cancer
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 29 Feb 2024
Spatz Medical Marks Milestone: Spatz3 Adjustable Gastric Balloon Launches in the U.S. in March 2024
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 19 Jan 2024
Kyverna Therapeutics Granted FDA Fast Track Designation for KYV-101 in the Treatment of Patients With Refractory Progressive Multiple Sclerosis
Regenerative Medicine Neurology FDA
 HSMN NewsFeed - 17 Jan 2024
Ratio Therapeutics Announces $50M Series B Financing to Advance Targeted Radiotherapies for Cancer Treatment
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 12 Jan 2024
Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer's Dementia
Diagnostics Neurology FDA
 HSMN NewsFeed - 27 Oct 2023
Laborie Medical Technologies Acquires Urotronic
Devices Urology Mergers & Acquisitions
 HSMN NewsFeed - 25 Oct 2023
Independent Scientific Paper by Doctors Using IceCure's ProSense(R) Published in Journal of Breast Imaging Presents Advantages of Cryoablation Breast Conserving Over Surgery in Early Breast Cancer Patients
Devices Oncology
 HSMN NewsFeed - 2 Oct 2023
MedAlliance Acquired by Cordis for up to USD 1.135 Billion
Devices Interventional Cardiology Mergers & Acquisitions
 HSMN NewsFeed - 20 Sep 2023
VerImmune Inc. announces over $3M Additional Funding
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 7 Sep 2023
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 10 May 2023
Sobi to Acquire CTI BioPharma
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 5 May 2023
Norlase Receives FDA 510(k) Clearance and CE Mark Approval For ECHO(TM) Green Pattern Laser
Devices Ophthalmology FDA
 HSMN NewsFeed - 12 Apr 2023
Geneos Therapeutics Secures $5 Million in Series A3 Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 30 Mar 2023
HistoSonics Announces First Ever Kidney Tumor Treatment Using Histotripsy
Devices Oncology
 HSMN NewsFeed - 22 Mar 2023
Flare Therapeutics Announces Oversubscribed $123 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 15 Mar 2023
Medtronic receives CE Mark approval for Affera(TM) Mapping and Ablation System to treat atrial arrhythmias
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 21 Feb 2023
Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Feb 2023
Ratio Therapeutics Announces $20M Series A Financing to Advance Targeted Radiotherapies for Cancer Treatment
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 29 Dec 2022
FDA Grants Appeal for Ardelyx's XPHOZAH(R) (tenapanor)
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 22 Dec 2022
INSIGHTEC Announces Positive Coverage Decision by Anthem for MR-Guided Focused Ultrasound to Treat Essential Tremor
Devices Neurology Reimbursement
 HSMN NewsFeed - 22 Nov 2022
U.S. Food and Drug Administration Approves CSL's Hemgenix(R) eEtranacogene dezaparvovec-drlb), the First Gene Therapy for Hemophilia B
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Nov 2022
Lipidio Pharmaceuticals Announces Close of Series A Extension Financing, Bringing Total Round to Over $20M
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Oct 2022
MedAlliance to be Acquired by Cordis
Devices Drug Delivery Mergers & Acquisitions
 HSMN NewsFeed - 16 Sep 2022
Marengo Therapeutics Advances First-In-Class Selective T cell Activator, STAR0602, into Human Trials in Solid Tumors and Enters Cooperative Research and Development Agreement with the National Cancer Institute
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Sep 2022
COUR Pharmaceuticals Announces $30M Financing Led by Alpha Wave Ventures
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Sep 2022
ViewRay Announces China NMPA Approval of its MRIdian(R) MRI-Guided Radiation Therapy for Cancer Patients
Devices Oncology Regulatory
 HSMN NewsFeed - 19 Aug 2022
Verismo Therapeutics Announces Submission of IND Application to the FDA for SynKIR-110TM, a KIR-CAR T-cell Immunotherapy Candidate
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 20 Jul 2022
AbbVie and iSTAR Medical Announce Strategic Alliance for the Treatment of Glaucoma
Devices Ophthalmology
 HSMN NewsFeed - 14 Jul 2022
Study shows that selection of breast cancer patients for adjuvant bisphosphonate therapy based on Inbiomotion's MAFTEST(R) reduces the risk of death in comparison with current clinical guidance
Diagnostics Oncology
 HSMN NewsFeed - 8 Jul 2022
Sobi to license loncastuximab tesirine from ADC Therapeutics
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 28 Jun 2022
Advanced NanoTherapies Announces Closing of Oversubscribed $7.2 Million Series A Financing
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 14 Jun 2022
Cordis-X Makes Strategic Investment in Adient Medical, Developer of First Fully Absorbable Inferior Vena Cava (IVC) Filter
Devices Venture Capital
 HSMN NewsFeed - 1 Jun 2022
MolecuLight Added to the ISWCAP 2022 Consensus Guidelines for Optimising Prevention of Surgical Wound Complications
Devices Wound Care
 HSMN NewsFeed - 10 May 2022
Genascence Announces First Close in Series A Financing led by Pacira BioSciences and Expands Board of Directors and Scientific Advisory Board
Regenerative Medicine Orthopaedic Venture Capital
 HSMN NewsFeed - 18 Apr 2022
BENDIT Technologies Receives U.S. Food and Drug Administration 510(k) Clearance of its Bendit 021" Steerable Microcatheter
Devices Interventional FDA
 HSMN NewsFeed - 14 Mar 2022
IDEAYA and Pfizer Expand Clinical Trial Collaboration and Supply Agreements for Evaluation of Darovasertib and Crizotinib Combination in Metastatic Uveal Melanoma and Additional cMET-Driven Tumors
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Mar 2022
AiM Medical Robotics Appoints Dr. Jonathan M. Sackier as Chief Medical Officer
Devices Surgery Personnel
 HSMN NewsFeed - 2 Mar 2022
Valencia Technologies Announces FDA Approval of eCoin(R) Therapy to Treat Urinary Urge Incontinence
Devices Urology FDA
 HSMN NewsFeed - 31 Jan 2022
Spatz3 Adjustable Balloon Delivers the Highest Weight Loss Results
Devices Gastroenterology
 HSMN NewsFeed - 26 Jan 2022
Kyverna Therapeutics Closes $85 Million Series B Financing led by Northpond Ventures
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Jan 2022
Lyra Therapeutics Announces Initiation of LYR-210 Pivotal Phase 3 ENLIGHTEN Program in Surgically Naïve Chronic Rhinosinusitis Patients
Devices Drug Delivery
 HSMN NewsFeed - 15 Dec 2021
Medtronic Diabetes Receives FDA Warning Letter
Devices Drug Delivery Endocrinology FDA
 HSMN NewsFeed - 29 Nov 2021
HotSpot Therapeutics Closes $100M Series C to Advance First-in-Class Allosteric Drug Discovery Platform to the Clinic
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 26 Nov 2021
Radiaction Medical Unveils Innovative Radiation Protection Solution at RSNA 2021
Devices Radiology Product Launch
 HSMN NewsFeed - 24 Nov 2021
ViewRay Announces MRIdian MR-Guided Radiation Therapy Surpasses 2,300 Pancreatic Cancer Patients Treated Worldwide
Devices Oncology
 HSMN NewsFeed - 27 Oct 2021
NuVasive to Release Cutting-edge Virtual Reality Training for Lateral, Single-position Spine Surgery
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 19 Oct 2021
Accuray Unveils VOLO(TM) Ultra, the Latest Innovation for the Radixact(R) System, at ASTRO 2021
Devices Oncology
 HSMN NewsFeed - 12 Oct 2021
Dr. Paul Stoffels, Vice Chairman of the Executive Committee and Chief Scientific Officer of Johnson & Johnson To Retire, Effective December 31, 2021
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2021
Cartesian Therapeutics Strengthens Leadership Team With Hire of Miloš Miljković, M.D., as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Sep 2021
Open Stent Solution closes €2.5M Seed financing round for its breakthrough open-stent TMVR device
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 21 Sep 2021
Cytrellis Biosystems Completes $50 Million Series C Financing
Devices Dermatology Venture Capital
 HSMN NewsFeed - 9 Sep 2021
Obsidian Therapeutics Announces Closing of $115 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Jul 2021
Ring Therapeutics Raises $117 Million in Series B Funding to Expand Novel Vector Platform to Unlock the Full Potential of Gene Therapy
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jul 2021
Hemab Raises US$ 55M Series A to Advance Next Generation Therapeutics for Bleeding and Thrombosis Disorders
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Jul 2021
Hyalex Orthopaedics receives FDA Breakthrough Device Designation for novel HYALEX(R) Cartilage System
Devices Orthopaedic FDA
 HSMN NewsFeed - 7 Jul 2021
Elekta optimizes treatment times for cancer patients via proactive service innovation
Devices Oncology
 HSMN NewsFeed - 9 Jun 2021
ViaCyte Announces Closing of $45 Million Financing to Advance Broadest Portfolio of Stem Cell-Derived Therapies for Type 1 Diabetes
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 8 Jun 2021
Bausch & Lomb and Lochan Enter Into Agreement to Develop the Next-Generation of eyeTELLIGENCE(TM) Clinical Decision Support Software
Devices Ophthalmology
 HSMN NewsFeed - 1 Jun 2021
Amgen and Kyowa Kirin to Jointly Develop and Commercialize KHK4083, a Phase 3-Ready, Potential First-In-Class Treatment for Atopic Dermatitis
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 24 May 2021
Eliem Therapeutics Announces $60 Million Series B Financing
Biopharmaceuticals Neurology Venture Capital
 HSMN NewsFeed - 18 May 2021
Interius BioTherapeutics Raises $76M Series A Financing to Advance Breakthrough Cell and Gene Therapy Platform
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 17 May 2021
Milestone Pharmaceuticals Announces Exclusive License Agreement with Ji Xing Pharmaceuticals to Develop and Commercialize Etripamil for PSVT in Greater China
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 7 May 2021
Perosphere Technologies Announces CE-IVD Marking of the Perosphere Technologies PoC Coagulometer System for DOAC and Heparin Testing
Devices Diagnostics Regulatory
 HSMN NewsFeed - 29 Apr 2021
BD Announces Enrollment in Post-Market Studies of the WavelinQ(TM) Arteriovenous Endovascular Fistula
Devices
 HSMN NewsFeed - 21 Apr 2021
Medtronic Receives U.S. FDA Approval for Pipeline(TM) Flex Embolization Device with Shield Technology(TM)
Devices Interventional FDA
 HSMN NewsFeed - 14 Apr 2021
HotSpot Therapeutics Appoints Timothy Reilly as Chief Development Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Apr 2021
MedShape Appoints Greg Berlet, MD as Chief Medical Officer
Devices Orthopaedic Personnel
 HSMN NewsFeed - 6 Apr 2021
Mineralys Therapeutics Closes $40 Million Series A Funding
Biopharmaceuticals Cardiology Venture Capital Personnel
 HSMN NewsFeed - 18 Feb 2021
OncoSec Appoints Bridget O'Keeffe, Ph.D. as Vice President of Clinical Development
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 16 Feb 2021
Akan Biosciences Announces FDA Acceptance of IND Application for StroMel(TM) in Osteoarthritis of Knee
Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 12 Feb 2021
The Lancet Publishes Libtayo(R) (cemiplimab) Data Showing Extended Overall Survival in Patients with First-line Advanced Non-small Cell Lung Cancer with PD-L1 Expression of ≥50%
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Jan 2021
Theolytics raises $6.8 million Series A round co-led by Epidarex Capital and Taiho Ventures to advance viral cancer therapies
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Dec 2020
Anixa Biosciences and Cleveland Clinic Announce FDA Clearance to Initiate Clinical Trial of Breast Cancer Vaccine
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 15 Dec 2020
Medtronic's OsteoCool(TM) Procedure Shows Significant, Swift Pain Relief and Sustained Improvement for Cancer Patients
Devices Interventional Oncology
 HSMN NewsFeed - 11 Dec 2020
BAVENCIO(R) (avelumab) Receives Positive CHMP Opinion for First-Line Maintenance Treatment of Locally Advanced or Metastatic Urothelial Carcinoma
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 3 Dec 2020
Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
Biopharmaceuticals Oncology
 HSMN NewsFeed - 17 Nov 2020
Corvia Medical Completes Randomization In REDUCE LAP-HF II Pivotal Trial And Gains FDA Authorization To Provide Continued Access For The Corvia Atrial Shunt
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 10 Nov 2020
Cytocom, Inc. Appoints Taunia Markvicka, PharmD., MBA, Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2020
Citrine Medicine Advances Efforts to Create the Very First Rare Disease Ecosystem in China Through Strategic Partnership with Bioprojet to License Exclusive Rights for the Use of Orphan Narcolepsy Therapy Wakix(R) (pitolisant)
Biopharmaceuticals Licensing
 HSMN NewsFeed - 27 Oct 2020
Steven Yecies Joins Javelin Oncology as Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 27 Oct 2020
Caris Life Sciences Raises $310 Million in Growth Capital from a Broad Syndicate of Leading Investors
Diagnostics Venture Capital Personnel
 HSMN NewsFeed - 6 Oct 2020
Caris Life Sciences Appoints Brian Lamon, Ph.D., as Chief Business Officer, Head of BioPharma Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Sep 2020
Relief and NeuroRx Announce Partnership for Global Commercialization of RLF-100(TM) and Selection of Commercial Partners
Biopharmaceuticals
 HSMN NewsFeed - 10 Sep 2020
Medtronic Study Finds Opioid-Induced Respiratory Depression in the Hospital More Common and Costly
Devices Monitoring
 HSMN NewsFeed - 1 Sep 2020
10,000th Patient Receives Treatment with ViewRay's MRIdian System
Devices Radiology Oncology
 HSMN NewsFeed - 21 Aug 2020
Cipla and Stempeutics collaborate for launch of Stempeucel(R), first 'Made in India' Cell Therapy to treat Critical Limb Ischemia (CLI)
Biopharmaceuticals Regenerative Medicine
 HSMN NewsFeed - 22 Jul 2020
BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities
Diagnostics Oncology FDA
 HSMN NewsFeed - 13 Jul 2020
Healthcare Sales & Marketing Network Reports Record FindReps(R) Activity
Devices Diagnostics Biopharmaceuticals Distribution
 HSMN NewsFeed - 8 Jul 2020
Lumenis Launches Next-Generation MOSES(TM) 2.0 Holmium Laser Technology
Devices Urology Product Launch
 HSMN NewsFeed - 7 Jul 2020
Caris Precision Oncology Alliance Welcomes Penn's Abramson Cancer Center
Diagnostics Oncology
 HSMN NewsFeed - 25 Jun 2020
Long-Term Results from SABR-COMET Further Demonstrate Effectiveness of Stereotactic Ablative Radiotherapy for Comprehensive Treatment of Metastatic Cancers
Devices Oncology
 HSMN NewsFeed - 22 Jun 2020
Cipla Launches CIPREMI (remdesivir Lyophilised Powder for Injection 100 mg), the Only U.S. FDA Approved Emergency Use Authorisation (EUA) Treatment for Patients With Severe COVID-19 Disease
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 16 Jun 2020
Cardiff Oncology Secures $13.5 Million Equity Investment from Biotech-Focused Fundamental Institutional Investors Acorn Bioventures and CAM Capital
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 May 2020
HotSpot Therapeutics Completes $65 Million Series B Financing to Advance Pipeline of Novel Allosteric Medicines
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 21 May 2020
Cipla Receives Final Approval for Generic Version of Migranal(R) (Dihydroergotamine Mesylate Nasal Spray 4mg/mL) With a Competitive Generic Therapy Designation
Biopharmaceuticals Generics FDA Product Launch
 HSMN NewsFeed - 11 May 2020
CorVent Medical, A Coridea Portfolio Company, Closes $4.5M Seed Financing To Commercialize The First Single-Use, Critical Care Ventilator
Devices Venture Capital
 HSMN NewsFeed - 4 May 2020
Enteris BioPharma Appoints Rajiv Khosla, Ph.D., as Chief Executive Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 29 Apr 2020
First truly biocompatible MIGS implant from iSTAR Medical shows consistently outstanding efficacy in patients with glaucoma
Devices Ophthalmology
 HSMN NewsFeed - 20 Apr 2020
Pi-Cardia Closes a $27 Million Financing led by Sofinnova Partners to Continue Clinical Trials With Its Leaflex(TM) Aortic Valve Technology
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 15 Apr 2020
Indivumed Launches Global Oncology Alliance For Personalized Medicine ("Onco AI-Med")
Biopharmaceuticals Oncology
 HSMN NewsFeed - 14 Apr 2020
Caris Life Sciences Appoints Dr. Chadi Nabhan as Chairman of Precision Oncology Alliance
Diagnostics Oncology Personnel
 HSMN NewsFeed - 31 Mar 2020
Caris Life Sciences Launches MI FOLFOXai, Improving Overall Survival by 50% for Metastatic Colorectal Cancer Patients
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 27 Mar 2020
Cipla Receives Final Approval for Generic Version of AstraZeneca Pharmaceutical's Nexium(R) (Esomeprazole for Oral Suspension 10mg, 20mg and 40mg)
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 25 Mar 2020
Healthcare Sales & Marketing Network Completes Spinoff of FindReps(R) LLC, Preps Expansion Beyond Independent Sales Reps
Devices Diagnostics Biopharmaceuticals Distribution
 HSMN NewsFeed - 11 Feb 2020
Caris Life Sciences Appoints New Executive Medical Director
Diagnostics Oncology Personnel
 HSMN NewsFeed - 10 Feb 2020
Enteris BioPharma Appoints Gary A. Shangold, MD, as Chief Medical Officer
Biopharmaceuticals Drug Delivery Personnel
 HSMN NewsFeed - 10 Feb 2020
Biohaven's Troriluzole Study For Generalized Anxiety Disorder (GAD) Misses Primary Endpoint
Biopharmaceuticals
 HSMN NewsFeed - 31 Jan 2020
AbbVie Receives Positive CHMP Opinion for VENCLYXTO(R) as a Chemotherapy-Free Combination Regimen for Patients with Previously Untreated Chronic Lymphocytic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 28 Jan 2020
John Quisel, JD, PhD Joins Disc Medicine as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Dec 2019
Caris Life Sciences Launches First Ever Molecular AI Product: A Clinical Genomic Profiling Similarity Score
Diagnostics Oncology Product Launch
 HSMN NewsFeed - 4 Dec 2019
Vicarious Surgical Announces Breakthrough Designation by the FDA, Appoints Scott Huennekens to Board of Directors
Devices Surgery FDA Personnel
 HSMN NewsFeed - 14 Nov 2019
Bayer and Dewpoint Therapeutics partner to research new treatments for cardiovascular and gynecological diseases
Biopharmaceuticals Cardiology Licensing
 HSMN NewsFeed - 29 Oct 2019
Disc Medicine Completes $50 Million Series A Financing led by Novo Holdings A/S to Advance New Therapies Addressing Ineffective Red Blood Cell Production
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Oct 2019
European Symposium to Advance Adoption of MRI-Guided Radiation Therapy
Devices Radiology Oncology
 HSMN NewsFeed - 4 Oct 2019
Results from Clinical Studies using MolecuLight i:X(R) Fluorescence Imaging System Featured Prominently at the Wounds Canada 2019 Annual Conference
Diagnostics Wound Care
 HSMN NewsFeed - 23 Sep 2019
Mallinckrodt Announces Positive Top-line Results from Pivotal Phase 3 Clinical Trial of StrataGraft(R) Regenerative Tissue in Patients with Deep Partial-thickness Thermal Burns
Regenerative Medicine
 HSMN NewsFeed - 11 Sep 2019
Immunexpress Appoints Jane Papadaki Markley as VP of Market Development and Commercial Operations
Diagnostics Personnel
 HSMN NewsFeed - 9 Sep 2019
Thermo Fisher Scientific Signs Agreement with Lilly Oncology for Companion Diagnostic to be Used with RET Inhibitor
Diagnostics Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 14 Aug 2019
NuVasive Specialized Orthopedics Reaches 10,000 Nail Implant Milestone of the Precice(R) System for Limb Lengthening
Devices Orthopaedic
 HSMN NewsFeed - 12 Aug 2019
binx health Receives FDA 510(k) Clearance For Rapid Point Of Care Platform For Women's Health
Diagnostics FDA
 HSMN NewsFeed - 17 Jul 2019
U.S. FDA Accepts Allergan's New Drug Application for Bimatoprost Sustained-Release in Patients with Open-Angle Glaucoma or Ocular Hypertension
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 12 Jul 2019
Elekta to Demonstrate Leadership in Precision Radiation Medicine at AAPM with Launch of new QA Portfolio
Devices Oncology Product Launch
 HSMN NewsFeed - 1 Jul 2019
Cardiac Dimensions Reaches 1,000 Implants Of Carillon(R) System, A Minimally Invasive Treatment For Functional Mitral Regurgitation
Devices Interventional Cardiology
 HSMN NewsFeed - 1 Jul 2019
Century Therapeutics launches with USD 250M financing for induced pluripotent stem cell (iPSC) allogeneic cell therapy platform
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 26 Jun 2019
Encoded Therapeutics, Inc. Announces $104 Million Series C Financing to Advance Lead Gene Therapy Program in Dravet Syndrome and Unveils its Precision Gene Therapy Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 17 May 2019
U.S. FDA Approves GATTEX(R) (teduglutide) for Children 1 Year of Age and Older With Short Bowel Syndrome (SBS)
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 9 May 2019
Varian Acquires CyberHeart
Devices Oncology Mergers & Acquisitions
 HSMN NewsFeed - 1 May 2019
Caris Life Sciences Acquires Pharmatech
Diagnostics Oncology Mergers & Acquisitions
 HSMN NewsFeed - 15 Apr 2019
Data on Impact of Revised Consensus Recommendations on Time to Treatment and Serum Creatinine (SCr) at Treatment Start for Patients with Hepatorenal Syndrome Type 1 (HRS-1) Presented at the 2019 International Liver Congress(TM) (EASL)
Biopharmaceuticals
 HSMN NewsFeed - 25 Mar 2019
Aprea Therapeutics Appoints Dr. Eyal C. Attar as Chief Medical Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 28 Jan 2019
First-In-Human Case Using Biostage's Bioengineered Esophageal Implant is Presented at Major Surgical Meeting
Devices Regenerative Medicine
 HSMN NewsFeed - 22 Jan 2019
European Commission Approves BLINCYTO(R) (blinatumomab) In Patients With Philadelphia Chromosome Negative Minimal Residual Disease-Positive B-cell Precursor Acute Lymphoblastic Leukemia
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 8 Jan 2019
Cygnal Therapeutics Appoints Pearl S. Huang as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2019
Protagonist Therapeutics Appoints Suneel K. Gupta, Ph.D., as Executive Vice President of Clinical Operations and Pharmacology
Biopharmaceuticals Personnel
 HSMN NewsFeed - 21 Dec 2018
Mallinckrodt And NPXe Announce First Patient Enrolled In Phase 3 Trial Of Inhaled Xenon Gas Therapy
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 11 Dec 2018
Positive Payor Policy Covering coflex(R) by Select Health of South Carolina for the Surgical Treatment of Lumbar Spinal Stenosis
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 5 Dec 2018
Vast Therapeutics Announces Series A Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 Dec 2018
TIGR(R)Matrix shows promising results when used for incisional hernia prevention in septic patients undergoing laparoscopy
Devices Surgery
 HSMN NewsFeed - 27 Nov 2018
Positive Payor Policy Covering coflex(R) by AmeriHealth Caritas for the Surgical Treatment of Lumbar Spinal Stenosis
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 26 Nov 2018
BlueRock Therapeutics Appoints Min Wang, J.D., Ph.D., as Chief Legal and Administrative Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 8 Nov 2018
Mr. Matthew Dallas and Mr. Jeffrey Young Appointed to Biostage Board of Directors
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Nov 2018
Ms. Ting Li Appointed to Biostage Board of Directors
Regenerative Medicine Personnel
 HSMN NewsFeed - 6 Nov 2018
Biostage awarded $1.1 million Phase II NIH SBIR Fast-Track grant to develop Cellspan(TM) Esophageal Implant (CEI) as a novel treatment for pediatric esophageal atresia
Regenerative Medicine
 HSMN NewsFeed - 25 Oct 2018
Skyline Urology Acquires First ExactVu(TM) Micro-Ultrasound System in California for Real-Time Targeted Prostate Biopsies
Devices Urology
 HSMN NewsFeed - 23 Oct 2018
CavoGene LifeSciences Licenses Novel Gene Therapy for CNS Disorders
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 18 Oct 2018
Olympus 3D/FlexDex(R) for Minimal Access Surgery Simplifies Suturing, Redefines Robotics
Devices Surgery Product Launch
 HSMN NewsFeed - 3 Oct 2018
Trovagene Announces Exclusive License Agreement with MIT for Combination Therapy of Anti-Androgens and Polo-like Kinase Inhibitors in Prostate Cancer
Biopharmaceuticals Oncology Licensing
 HSMN NewsFeed - 20 Sep 2018
BlueRock Therapeutics Appoints Shane Kovacs as Chief Business and Financial Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 13 Sep 2018
Olympus Introduces EZ Shot 3 Plus 25 G EUS Needle with Enhanced Maneuverability for Uncompromised Access to Any Lesion, Consistent Performance to Potentially Reduce Procedural Costs and Procedure Time
Devices Oncology FDA Product Launch
 HSMN NewsFeed - 17 Jul 2018
HotSpot Therapeutics Completes $45 Million Series A Financing to Advance New Approach to Allosteric Drug Discovery
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Jul 2018
NeuroTrauma Sciences and Henry Ford Health System Announce Research and License Agreements to Develop Exosome Technology for Neurological Injury
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 15 Jun 2018
ACell, Inc. Announces Ventral Hernia Data Presented at Abdominal Wall Reconstruction Conference
Devices Surgery
 HSMN NewsFeed - 12 Jun 2018
Vergent Bioscience Raises $8.7 Million in Series A Financing Led by Spring Mountain Capital
Diagnostics Oncology Venture Capital
 HSMN NewsFeed - 7 Jun 2018
BIOMODEX Raises an Additional $15M in Series A Funding
Devices Venture Capital
 HSMN NewsFeed - 30 May 2018
Olympus Launches the DualKnife J, an ESD Electrosurgical Knife That Shortens Procedure Time
Devices Gastroenterology Product Launch
 HSMN NewsFeed - 29 May 2018
Zeto Announces First Dry Electrode, Wireless EEG Headset Approved by FDA for Clinical Use
Devices Monitoring Neurology FDA
 HSMN NewsFeed - 24 May 2018
IMBRUVICA(R) (ibrutinib) Plus GAZYVA(R) (obinutuzumab) Phase 3 iLLUMINATE Trial for First-Line Therapy of Chronic Lymphocytic Leukemia (CLL) Patients Met Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 16 May 2018
Protagonist Therapeutics Appoints Bryan Giraudo to Board of Directors
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 3 May 2018
CytRx Corporation Names Eric L. Curtis as Its President and Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 3 May 2018
Paradigm Spine Announces NASS Coverage Policy Recommendation For coflex(R) Interlaminar Stabilization(R)
Devices Neurosurgery Orthopaedic Reimbursement
 HSMN NewsFeed - 2 May 2018
Paradigm Spine Receives FDA Pre-Market Approval (PMA) For First Of Its Kind Disposable Instrument Kit
Devices Orthopaedic Neurosurgery FDA
 HSMN NewsFeed - 1 May 2018
Regeneron and Sanofi to Lower Net Price of Praluent(R) (alirocumab) Injection in Exchange for Straightforward, More Affordable Patient Access for Express Scripts Patients
Biopharmaceuticals Reimbursement
 HSMN NewsFeed - 25 Apr 2018
Dermtreat Appoints Nishan de Silva, M.D., as CEO; Establishes North American Headquarters in San Diego
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 19 Apr 2018
Philips showcases dedicated radiation oncology workflow solutions spanning image acquisition to treatment planning at ESTRO 2018
Devices Radiology Oncology
 HSMN NewsFeed - 16 Apr 2018
TELA Bio Announces Series B Investment by Checkmate Capital
Devices Surgery Venture Capital
 HSMN NewsFeed - 16 Apr 2018
Apitope Announces Positive Results with Novel Treatment for Graves' Disease
Biopharmaceuticals
 HSMN NewsFeed - 12 Apr 2018
TransMedics, Inc. Receives FDA Pre-Market Approval (PMA) for its OCS(TM) Lung System for Near-Physiologic Preservation and Assessment of Lungs for Transplantation
Devices Surgery FDA
 HSMN NewsFeed - 4 Apr 2018
Arvinas Completes $55 Million Series C Financing to Advance Protein Degradation Platform
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 27 Mar 2018
Singlera Genomics Raises $60 Million in Series A+ Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 9 Mar 2018
SuperSonic Imagine to Showcase Aixplorer(R) Ultimate at 28th Annual Interdisciplinary Breast Center Conference
Devices Product Launch
 HSMN NewsFeed - 27 Feb 2018
VitalConnect Launches Continuous Patient Monitoring Platform in Hospitals Nationwide
Devices Monitoring Product Launch
 HSMN NewsFeed - 27 Feb 2018
BIOLASE Announces Memorandum Of Understanding With S-Ray To Market, Sell Disruptive Radiation-Free Dental Imaging Device
Devices Dental Distribution
 HSMN NewsFeed - 8 Feb 2018
Novo Nordisk Launches Rebinyn(R) in the United States for People with Hemophilia B
Biopharmaceuticals Product Launch
 HSMN NewsFeed - 29 Jan 2018
Paradigm Spine Announces Landmark Publication Of coflex(R) Vs. Decompression Alone In The Journal Of Neurosurgery Spine
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 29 Jan 2018
SyntheticMR AB - Segmentation and Quantification of Brain Tissue, and Industry First Myelin Volume Measurements in SyMRI now FDA Cleared
Devices Radiology Neurology FDA
 HSMN NewsFeed - 23 Jan 2018
Disarm Therapeutics Appoints Thomas Engber as Senior Vice President, Head of Neuropharmacology and Translational Sciences
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 16 Jan 2018
RXi Pharmaceuticals Announces Business Strategy to Focus on Immuno-Oncology Programs to Accelerate Growth
Biopharmaceuticals Oncology
 HSMN NewsFeed - 19 Dec 2017
Disarm Therapeutics Appoints Peter Keller Chief Business Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 18 Dec 2017
Novartis multiple sclerosis therapy fingolimod granted FDA Breakthrough Therapy designation for pediatric MS
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 18 Dec 2017
Neurotrope Appoints Charles S. Ryan as Chief Executive Officer
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 14 Dec 2017
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 7 Dec 2017
VitalConnect Secures Fifth U.S. FDA Clearance for Patient Monitoring Device
Devices Monitoring FDA
 HSMN NewsFeed - 5 Dec 2017
Cocoon Biotech Appoints Dr. Annalisa Jenkins as Executive Chair of the Board
Biopharmaceuticals Drug Delivery Ophthalmology Personnel
 HSMN NewsFeed - 30 Nov 2017
Fractyl Completes $44 Million Series D Financing to Advance New Treatment for Type 2 Diabetes
Devices Endocrinology Venture Capital
 HSMN NewsFeed - 30 Nov 2017
FDA Clears First Medical Device Accessory for Apple Watch(R)
Devices Cardiology FDA
 HSMN NewsFeed - 20 Nov 2017
Paradigm Spine, LLC Announces - Highmark, Inc. Is 1st Private Payor To Issue Exclusive Positive Coverage Policy For coflex(R) Interlaminar Stabilization(R) Treatment Of Lumbar Spinal Stenosis
Devices Orthopaedic Neurosurgery Reimbursement
 HSMN NewsFeed - 16 Nov 2017
FDA Announces Comprehensive Regenerative Medicine Policy Framework
Regenerative Medicine FDA
 HSMN NewsFeed - 9 Nov 2017
Johnson & Johnson Medical Devices Companies Unveils State of the Art "Engineering Studio" at Texas Medical Center to Accelerate Medical Devices Development
Devices
 HSMN NewsFeed - 9 Nov 2017
NICE Recommends Mavenclad (Cladribine Tablets) for Highly Active Multiple Sclerosis
Biopharmaceuticals Neurology Regulatory
 HSMN NewsFeed - 31 Oct 2017
VitalConnect Raises $38 Million in a Series C Equity Financing Round
Devices Monitoring Venture Capital
 HSMN NewsFeed - 5 Oct 2017
Vestagen Closes $9.5 Million Financing to Advance Adoption of Its VESTEX(R) Active Barrier Healthcare Uniforms
Devices Venture Capital
 HSMN NewsFeed - 2 Oct 2017
Mallinckrodt Licenses Inhaled Xenon Gas Therapy Development Product
Biopharmaceuticals Licensing
 HSMN NewsFeed - 20 Sep 2017
Arvinas Appoints Dr. John Houston as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Sep 2017
Trial Results Show Astute Medical's NephroCheck Test With Guided Intervention Prevents Acute Kidney Injury, Shortens Hospital Stays And Reduces Costs
Diagnostics
 HSMN NewsFeed - 28 Aug 2017
CSL Behring to Acquire Biotech Company Calimmune and its Proprietary Stem Cell Gene Therapy Platform
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Aug 2017
Lexicon Pharmaceuticals Reports Additional Positive Data From Pivotal Phase 3 inTandem2 Study Of Sotagliflozin
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 8 Aug 2017
First FDA-Approved Treatment For ALS In 22 Years Now Available In U.S.
Biopharmaceuticals Neurology Product Launch
 HSMN NewsFeed - 7 Aug 2017
Biostage Announces the Use of Its Esophageal Implant Product Candidate in a Patient
Devices Regenerative Medicine
 HSMN NewsFeed - 25 Jul 2017
Early Treatment Is Revolutionizing Outcome Of Burn Scars
Devices Dermatology
 HSMN NewsFeed - 3 Jul 2017
New Analysis Reveals First-Line Treatment Data on SIR-Spheres(R) Y-90 Resin Microspheres for Patients with Liver Metastases from Right-Sided Primary Colon Cancer
Devices Oncology
 HSMN NewsFeed - 26 Jun 2017
Provention Bio, Inc. Secures $28.4 Million Founding Financing to Fund Development Targeting the Interception and Prevention of Immune-Mediated Disease
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 22 Jun 2017
DelMar Pharmaceuticals Receives Institutional Review Board Approval for Pivotal Phase 3 Clinical Trial of VAL-083 in Refractory GBM
Biopharmaceuticals Oncology
 HSMN NewsFeed - 9 Jun 2017
Camber Spine Technologies Appoints Two New Area Sales Directors
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 8 Jun 2017
Protagonist Therapeutics Appoints Five Prime Therapeutics CEO, Lewis T. "Rusty" Williams, to its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 19 May 2017
Iterum Secures $65 Million in Series B Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 10 May 2017
Bioness and Ottobock Announce Strategic European Distribution Partnership
Devices Distribution
 HSMN NewsFeed - 1 May 2017
NEUROTROPE Announces Positive Top-Line Results From Phase 2 Study of Bryostatin-1 for Moderate to Severe Alzheimer's Disease
Biopharmaceuticals Neurology
 HSMN NewsFeed - 28 Apr 2017
Rodo Medical and Straumann Group enter into Distribution Agreement Outside North America; Straumann Increases Its Investment in Rodo Medical
Devices Dental Distribution
 HSMN NewsFeed - 30 Mar 2017
Third Rock Ventures Launches Tango Therapeutics with $55 Million Series A Investment
Biopharmaceuticals Oncology Personnel Venture Capital
 HSMN NewsFeed - 27 Mar 2017
Bridge Medicines Appoints William J. Polvino, M.D., As Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Mar 2017
New England Journal of Medicine Publishes Pivotal Phase III Data for CSL Behring's Subcutaneous C1-Esterase Inhibitor in HAE Patients
Biopharmaceuticals
 HSMN NewsFeed - 16 Mar 2017
Biostage Promotes Saverio La Francesca, M.D. to President
Devices Regenerative Medicine Personnel
 HSMN NewsFeed - 16 Mar 2017
Moximed Closes Oversubscribed $50MM Financing Round
Devices Orthopaedic Venture Capital Personnel
 HSMN NewsFeed - 17 Feb 2017
Biostage Announces Closing of $8.0 Million Public Offering
Regenerative Medicine Venture Capital
 HSMN NewsFeed - 13 Feb 2017
DePuy Synthes Launches ViviGen Formable(TM) Cellular Bone Matrix, Providing a New Cellular Allograft with Alternative Consistency for Spinal Fusion Surgery
Devices Orthopaedic Neurosurgery Product Launch
 HSMN NewsFeed - 2 Feb 2017
Glaukos Corporation Promotes Chris M. Calcaterra to Chief Operating Officer
Devices Ophthalmology Personnel
 HSMN NewsFeed - 20 Jan 2017
Verastem Announces Executive Leadership Appointments and Changes
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 11 Jan 2017
US Endovascular Announces John F. Vacha & Paul A. Tyska Join The Partnership
Devices Distribution Personnel
 HSMN NewsFeed - 12 Dec 2016
Study Published in Journal of Glaucoma Evaluates a Single Glaukos iStent(R) Trabecular Micro-Bypass Stent as a Standalone Procedure
Devices Ophthalmology
 HSMN NewsFeed - 22 Nov 2016
Shockwave Medical Raises $45 Million in Series C Financing to Further Advance Novel Lithoplasty Treatment for Calcified Arteries
Devices Interventional Venture Capital
 HSMN NewsFeed - 15 Nov 2016
Integrated Endoscopy Significantly Expands Management Team in Advance of U.S. Product Launch
Devices Orthopaedic Personnel
 HSMN NewsFeed - 8 Nov 2016
KATOR Receives FDA Clearance for Knotless Suture Anchor System
Devices Orthopaedic Surgery FDA
 HSMN NewsFeed - 4 Nov 2016
CorWave Raises $17.1 Million in Series B Financing
Devices Cardiology Venture Capital Personnel
 HSMN NewsFeed - 17 Oct 2016
Allergan and Vitae Pharmaceuticals Announce Expiration of HSR Waiting Period for Allergan's Proposed Acquisition of Vitae
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Oct 2016
InspireMD Announces Independent Study Published in the Journal of Endovascular Therapy That Continues to Support the Clinical Benefit and Utility of the CGuard Embolic Prevention System
Devices Interventional
 HSMN NewsFeed - 17 Oct 2016
Teva Receives Positive Opinion from European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) to Extend Indication of Trisenox(R) for First Line Treatment of Low- to Intermediate Risk Acute Promyelocytic Leukemia (APL)
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 29 Sep 2016
Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy
Diagnostics Personnel
 HSMN NewsFeed - 28 Sep 2016
Abbott Receives FDA Approval for the FreeStyle Libre Pro(TM) System, a Revolutionary Diabetes Sensing Technology for Healthcare Professionals to Use with Their Patients
Devices Monitoring Endocrinology FDA
 HSMN NewsFeed - 14 Sep 2016
Third Rock Ventures Launches Relay Therapeutics with $57 Million Series A Financing to Create Breakthrough Medicines Based on Protein Motion
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Sep 2016
BlueWind Medical Announces CE-Mark for the BlueWind VIVENDI(TM) Miniature Implanted Wireless Stimulator to Treat Peripheral Pain
Devices Neurology Regulatory
 HSMN NewsFeed - 2 Aug 2016
pSivida Corp and Hospital for Special Surgery Innovation Center Announce Opening of IND for Sustained-Release Implant for Severe Knee Osteoarthritis
Devices Drug Delivery Orthopaedic
 HSMN NewsFeed - 29 Jul 2016
Edge Therapeutics Announces First Patient Treated in Phase 3 NEWTON 2 Study of EG-1962 in Adult Patients with Aneurysmal Subarachnoid Hemorrhage
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 26 Jul 2016
CellMax Life Raises $14M in Venture Funding, Launches Precision Cancer Testing Company for Early Detection & Optimal Management of Cancer
Diagnostics Personalized Medicine Venture Capital
 HSMN NewsFeed - 13 Jul 2016
Second Genome Appoints Glenn Nedwin, Ph.D., as Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2016
William D. Waddill, Calithera CFO, Elected to Protagonist Therapeutics Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jul 2016
QT Vascular Receives CE Mark Clearance for Chocolate Heart(TM), a Novel Drug-Coated Coronary Balloon
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 29 Jun 2016
Biostage Files for FDA Orphan Drug Designation for Cellspan(TM) Esophageal Implant
Regenerative Medicine FDA
 HSMN NewsFeed - 16 Jun 2016
Merck’s KEYTRUDA(R) (pembrolizumab) Demonstrates Superior Progression-Free and Overall Survival Compared to Chemotherapy as First-Line Treatment in Patients with Advanced Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Jun 2016
BlueWind Medical Announces CE-Mark for the First in the World Miniature Wireless Neurostimulator to Treat Overactive Bladder
Devices Urology Neurology Regulatory
 HSMN NewsFeed - 14 Jun 2016
VitalConnect Announces Closure of $25 Million of Financing
Devices Monitoring Venture Capital
 HSMN NewsFeed - 6 Jun 2016
Vitae Pharmaceuticals Announces Appointment of Carole Sable, M.D., as Chief Medical Officer
Biopharmaceuticals Dermatology Personnel
 HSMN NewsFeed - 1 Jun 2016
Elekta’s Leksell Gamma Knife Icon Cleared for Use in Japan and United States
Devices Oncology Neurosurgery Regulatory
 HSMN NewsFeed - 26 May 2016
Third Installation of Elekta’s High-Field MR-Guided Linear Accelerator Underway at University Medical Centre Utrecht
Devices Oncology
 HSMN NewsFeed - 17 May 2016
Agenovir Completes $10.6 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 4 May 2016
Notal Vision Announces Appointment of Quinton Oswald as Chief Executive Officer
Devices Monitoring Ophthalmology Personnel
 HSMN NewsFeed - 22 Apr 2016
Accuray Hosts Regional AERO Users' Meeting
Devices Oncology
 HSMN NewsFeed - 14 Apr 2016
RefleXion Medical Raises $46 Million Series B Financing Led by KCK Group
Devices Oncology Venture Capital Personnel
 HSMN NewsFeed - 28 Mar 2016
Glaukos iStent(R) Trabecular Micro-Bypass Stent Approved in Japan
Devices Ophthalmology Regulatory
 HSMN NewsFeed - 7 Mar 2016
Avant Diagnostics and Amarantus Diagnostics to Combine Operations With Theranostics Health
Diagnostics Mergers & Acquisitions
 HSMN NewsFeed - 1 Mar 2016
Mazor Robotics' Renaissance(R) Guidance System Achieves New Clinical Milestone
Devices Neurosurgery
 HSMN NewsFeed - 9 Feb 2016
Aytu BioScience Announces First Commercial Sales for Company's MiOXSYS(TM) System for Male Infertility
Devices Urology Product Launch
 HSMN NewsFeed - 9 Feb 2016
Alder BioPharmaceuticals Strengthens and Expands Leadership Team Supporting Advancement of ALD403 Toward Future Commercialization
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Feb 2016
ProtoStar(TM) Announces the LifeWalker(TM) Upright, a New Medical Walker Designed to Enable Users to Stand Upright and Walk Safer and Longer for Improved Health
Devices Product Launch
 HSMN NewsFeed - 2 Feb 2016
Telesta Therapeutics Receives Complete Response Letter from FDA
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 1 Feb 2016
New Company ProtoStar(TM) Launched to Produce Safer, Next-Generation Assistive Mobility Products Designed to Reduce Fall Risk and Enable Users to Stand Upright and Walk Longer
Devices
 HSMN NewsFeed - 11 Jan 2016
Tensha Therapeutics To Be Acquired By Roche
Biopharmaceuticals Oncology Mergers & Acquisitions
 HSMN NewsFeed - 7 Jan 2016
EndoChoice(R) Enters Distribution Agreement with Chindex Medical Ltd. for China
Devices Distribution Gastroenterology
 HSMN NewsFeed - 7 Jan 2016
C4 Therapeutics Enters Strategic Drug Discovery Collaboration in the Promising New Field of Targeted Protein Degradation
Biopharmaceuticals
 HSMN NewsFeed - 7 Jan 2016
C4 Therapeutics Launches with $73 Million Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 30 Dec 2015
Braeburn Pharmaceuticals and Camurus Enroll First Patient in a Phase 3 Efficacy Trial of Long-acting Treatment for Opioid Dependence
Biopharmaceuticals
 HSMN NewsFeed - 22 Dec 2015
eFFECTOR Therapeutics Raises $40 Million Series B Financing
Biopharmaceuticals Oncology Venture Capital
 HSMN NewsFeed - 21 Dec 2015
Axonics Modulation Technologies Announces $38.5 Million Series B Financing
Devices Neurology Urology Venture Capital
 HSMN NewsFeed - 30 Nov 2015
St. Jude Medical Announces European Launch of the World’s First and Only Upgradeable, Non-Rechargeable, Burst-Enabled MR-Conditional SCS System
Devices Neurology Product Launch
 HSMN NewsFeed - 3 Nov 2015
Neurogastrx Appoints Baxter Phillips III as President and Chief Executive Officer
Biopharmaceuticals Gastroenterology Personnel
 HSMN NewsFeed - 21 Oct 2015
Arvinas Secures $41.6M Series B Financing - Appoints New Board Members
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 20 Oct 2015
Silk Road Medical Announces up to $57 Million in New Funding for Novel Approach to Preventing Strokes
Devices Interventional Venture Capital
 HSMN NewsFeed - 19 Oct 2015
Elekta highlights leading R&D program and reiterates financial ambitions
Devices Oncology Neurosurgery
 HSMN NewsFeed - 14 Oct 2015
MyoKardia Appoints Renowned Cardiovascular Medicine Expert Eric Topol, M.D., to Board of Directors
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 8 Sep 2015
Selecta Announces $38 Million Series E Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Sep 2015
Selecta Biosciences Appoints Earl E. Sands, MD, as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Aug 2015
Chiasma Appoints William H. Ludlam, M.D., Ph.D., as Vice President of Medical Affairs
Biopharmaceuticals Endocrinology Personnel
 HSMN NewsFeed - 20 Aug 2015
Alder BioPharmaceuticals Appoints Paul B. Cleveland to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Aug 2015
Axiobionics(R) Announces the Launch of its Newest Therapy Device: TripleFlex
Devices Neurology Product Launch
 HSMN NewsFeed - 10 Aug 2015
Inovio Pharmaceuticals Enters Into Strategic Cancer Vaccine Collaboration and License Agreement With MedImmune
Biopharmaceuticals Licensing
 HSMN NewsFeed - 5 Aug 2015
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 15 Jun 2015
Innocoll AG Announces First Patient Dosed in the Cogenzia COACT-2 Phase 3 Study for the Treatment of Diabetic Foot Infection
Devices Wound Care
 HSMN NewsFeed - 3 Jun 2015
Ardelyx to Raise $77.8 Million in a Private Placement and Announces New Product Candidate for the Treatment of Hyperkalemia to Begin Clinical Development in Mid-2015
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 3 Jun 2015
Ardelyx Regains Worldwide Development and Commercialization Rights for Its Late-Stage Development Candidate, Tenapanor, and Related Portfolio of NHE3 Compounds
Biopharmaceuticals Gastroenterology Acquisitions
 HSMN NewsFeed - 19 May 2015
Shockwave Medical Announces $40 Million in Funding for Novel Lithoplasty System to Treat Advanced Peripheral, Coronary Vascular and Aortic Valve Disease
Devices Interventional Cardiology Venture Capital
 HSMN NewsFeed - 12 May 2015
Paradigm Spine, LLC Announces The Publication Of Long-term Results Of Level 1 Data For coflex(R) Interlaminar Stabilization(R)
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 29 Apr 2015
Intact Vascular’s First-In-Man Clinical Study Results Published in the Journal of the American College Of Cardiology: Cardiovascular Interventions
Devices Interventional
 HSMN NewsFeed - 9 Apr 2015
Caris Life Sciences Appoints Dr. David Spetzler Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Apr 2015
FDA Expands Indication for EVARREST(R) Fibrin Sealant Patch
Devices Surgery FDA
 HSMN NewsFeed - 3 Apr 2015
Bruker Announces FDA Clearance for Second, Expanded Claim for the MALDI Biotyper CA System
Diagnostics FDA
 HSMN NewsFeed - 4 Mar 2015
Bristol-Myers Squibb Signs Exclusive Agreement with Bavarian Nordic for PROSTVAC(R), a Prostate-Specific Antigen-Targeting Cancer Immunotherapy
Biopharmaceuticals Licensing Oncology
 HSMN NewsFeed - 23 Jan 2015
The Medicines Company Receives CHMP Positive Opinions for Three Hospital Acute Care Products: KENGREXAL(TM) (cangrelor), ORBACTIV(TM) (oritavancin) and RAPLIXA(TM) (sealant powder)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Jan 2015
Elekta plans to introduce MRI-guided radiation therapy system in 2017
Devices Radiology Oncology
 HSMN NewsFeed - 17 Dec 2014
Inovio Pharmaceuticals Appoints Zane Yang, M.D. Vice President, Clinical Development, Oncology
Biopharmaceuticlas Oncology Personnel
 HSMN NewsFeed - 3 Dec 2014
Tal Medical Appoints Atul Pande, M.D., Former SVP and Head of Neurosciences at GSK, as Chief Medical Officer, EVP and SAB member
Devices Neurology Personnel
 HSMN NewsFeed - 2 Dec 2014
Xeltis Closes EURO 27 Million / USD 34 Million Series B Financing
Devices Cardiology Venture Capital
 HSMN NewsFeed - 6 Nov 2014
HD Medical Offers Viscope Md World’s First Visual Stethoscope with Murmur Detection at MEDICA
Devices Cardiology Product Launch
 HSMN NewsFeed - 24 Oct 2014
The TransMedics(R) Organ Care System (OCS(TM)) Heart Technology Was Used to Perform The World's First Series of Adult Human Heart Transplants From Donors After Circulatory Death (DCD Donors) at St Vincent's Hospital in Sydney, Australia
Devices Cardiology
 HSMN NewsFeed - 15 Oct 2014
Portal Instruments Completes Landmark $11 Million Series A Financing to Develop Innovative Drug Delivery Platform
Devices Drug Delivery Venture Capital
 HSMN NewsFeed - 15 Oct 2014
Selecta Announces More than $20 Million in Equity Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Aug 2014
Brainlab: First Patient Treatment with Revolutionary New Radiosurgery Software for Multiple Brain Metastases
Devices Oncology Neurosurgery
 HSMN NewsFeed - 25 Aug 2014
NovaBay Pharmaceuticals Deploys Direct Sales Force to Market i-Lid Cleanser Across the U.S.
Biopharmaceuticals Ophthalmology Distribution
 HSMN NewsFeed - 5 Aug 2014
CardioMEMS Heart Failure Monitoring System Receives Approval from CMS for New Technology Add-On Payment
Devices Cardiology Reimbursement
 HSMN NewsFeed - 25 Jul 2014
European Medicines Agency (EMA) Issues Positive Opinion, Recommends Full Approval of IMBRUVICA(R) (ibrutinib) for Treatment of Two Blood Cancers
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 Jul 2014
Shire Enters Strategic Licensing and Collaboration Agreement With ArmaGen
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 16 Jul 2014
MediWound Announces NexoBrid Marketing Approval From Israeli Ministry of Health
Biopharmaceuticals Wound Care Regulatory
 HSMN NewsFeed - 9 Jul 2014
CIMTEC announces spin-off company Focal Healthcare, Inc. to develop the new "gold standard" of targeted prostate biopsy and therapy devices for the management of prostate cancer
Devices Oncology Urology
 HSMN NewsFeed - 8 Jul 2014
Paradigm Spine, LLC Announces the Release of Two Independent Prospective Clinical Studies that Substantiate coflex(R) Interlaminar Stabilization After Decompression for the Treatment of Spinal Stenosis
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 30 Jun 2014
Allergan Announces R&D Pipeline Update and U.S. FDA Approval; Company to Host Conference Call Today, Monday, June 30th at 10:30 AM ET
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 23 Jun 2014
Dimension Therapeutics Raises $30M Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 18 Jun 2014
Lakewood-Amedex Raises $5.5 Million In Series C Preferred Stock Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 11 Jun 2014
RuiYi Closes $4 Million Venture Loan from Silicon Valley Bank
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 May 2014
MediWound Expands Distribution of NexoBrid to Russia Through Agreement With Genfa Medica
Biopharmaceuticals Wound Care Distribution
 HSMN NewsFeed - 1 May 2014
EndoGastric Solutions Names Industry Veteran Skip Baldino CEO
Devices Personnel
 HSMN NewsFeed - 24 Apr 2014
FDA Approves Roche's HPV Test for First-Line Primary Screening for Cervical Cancer
Diagnostics Oncology FDA
 HSMN NewsFeed - 28 Mar 2014
aTyr Pharma Appoints David M. Weiner, M.D., as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Mar 2014
Cutera Introduces Two New Laser Systems
Devices Dermatology Product Launch
 HSMN NewsFeed - 18 Mar 2014
On-X Life Technologies Prepares European Sales Force to Sell On-X(R) Plus 1.5(TM) Aortic Heart Valve
Devices Cardiology Product Launch
 HSMN NewsFeed - 13 Mar 2014
Umbra Applied Technologies Group Introduces New Blood Management System Powered by Cellgevity(TM)
Devices Product Launch
 HSMN NewsFeed - 26 Feb 2014
Immunome Appoints New Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Jan 2014
Pulmonary Embolism Trial Comparing Endovascular Ultrasound to Standard of Care Anticoagulation Published in the American Heart Association’s Journal, Circulation
Devices Interventional
 HSMN NewsFeed - 13 Jan 2014
Arno Therapeutics Expands Management Team With Additions of Two Scientific Leaders
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 13 Jan 2014
Galena Biopharma Acquires Mills Pharmaceuticals, LLC
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Jan 2014
Shield Therapeutics' ST10 Delivers Robust Results Meeting both Primary and Secondary Endpoints in the Pivotal AEGIS Phase 3 Programme for the Treatment of Iron Deficiency Anaemia in Inflammatory Bowel Disease
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 10 Dec 2013
Reverse Medical(R) Corporation Announces FDA 510k Clearance of the MVP(R)-5 Micro Vascular Plug for Peripheral Embolization
Devices Interventional FDA
 HSMN NewsFeed - 9 Dec 2013
Gecko Biomedical Raises €8 Million in Series A Financing to Advance Next-generation Tissue Adhesives for Wound Closure During Open and Minimally Invasive Surgery
Devices Wound Care Venture Capital
 HSMN NewsFeed - 27 Nov 2013
Over 110 Attend First Varian Edge(TM) Radiosurgery Symposium to Discuss Advances in Stereotactic Radiosurgery and Stereotactic Ablative Radiotherapy
Devices Oncology
 HSMN NewsFeed - 25 Nov 2013
Pixium Vision raises €15 million led by Sofinnova Partners
Devices Ophthalmology Venture Capital
 HSMN NewsFeed - 18 Nov 2013
Actinium Pharmaceuticals Announces Plans For Iomab(TM)-B Phase 3 Pivotal Trial Following Meeting With FDA
Biopharmaceuticals
 HSMN NewsFeed - 11 Nov 2013
Titan Spine Reaches Milestone of 18,000 Implanted Devices
Devices Orthopaedic Neurosurgery
 HSMN NewsFeed - 31 Oct 2013
Elixir Medical Announces Excellent 1-Year Safety and Efficacy Results for the CE-Marked Fully Bioresorbable DESolve(R) Novolimus Eluting Coronary Scaffold System
Devices Interventional Cardiology
 HSMN NewsFeed - 21 Oct 2013
Bayer's CONTOUR(R) NEXT LINK Cleared For Use With Medtronic's New MiniMed(R) 530G With Enlite(R)
Devices Drug Delivery Monitoring Endocrinology FDA
 HSMN NewsFeed - 3 Oct 2013
Pfizer Inc. Announces FDA Approval of DUAVEE(TM) (conjugated estrogens/ bazedoxifene) for the Treatment of Moderate-to-Severe Vasomotor Symptoms (Hot Flashes) Associated with Menopause and the Prevention of Postmenopausal Osteoporosis [1]
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Sep 2013
Medtronic Gains Approval of First Artificial Pancreas Device System with Threshold Suspend Automation
Devices Drug Delivery FDA
 HSMN NewsFeed - 17 Sep 2013
Dendreon Announces Marketing Authorization for PROVENGE(R) in the European Union
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 27 Jun 2013
Cepheid Receives FDA Clearance For Updated Xpert MRSA/SA Blood Culture (BC) Test
Diagnostics FDA
 HSMN NewsFeed - 25 Jun 2013
Mevion Medical Systems Secures $55 Million to Accelerate the Deployment of Its Revolutionary Cancer Treatment Technology
Devices Oncology Venture Capital
 HSMN NewsFeed - 17 Jun 2013
NGM Biopharmaceuticals and MedImmune, AstraZeneca's Biologics Arm, Announce Agreement to Discover and Develop Therapies for Diabetes and Obesity
Biopharmaceuticals Endocrinology
 HSMN NewsFeed - 20 May 2013
eFFECTOR Therapeutics Raises $45 Million in Series A Financing
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 16 May 2013
Echo Therapeutics to Unveil Symphony(R) CGM System in Webcast
Devices Endocrinology Monitoring
 HSMN NewsFeed - 10 May 2013
Uroplasty Announces STEP Study 3-Year Results Demonstrate Sustained Therapeutic Effects Of Percutaneous Tibial Nerve Stimulation
Devices Urology
 HSMN NewsFeed - 22 Apr 2013
Sanovas Launches Next Generation Surgical Imaging Technology
Devices Product Launch
 HSMN NewsFeed - 2 Apr 2013
BIND Therapeutics Appoints Gregory I. Berk, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 4 Mar 2013
The Radiosurgery Society(TM) Completes the 2013 Scientific Meeting Focused on Bridging the Gap: Working Together
Devices Oncology
 HSMN NewsFeed - 13 Feb 2013
Loma Vista Medical Reports That It is Ramping up Sales in U.S. and Europe of its FDA-Cleared and CE-Marked TRUE Dilatation(TM) Balloon Valvuloplasty Catheter Specifically Designed to Reduce ‘Rapid Pacing’ Time and Prevent Balloon Failure
Devices Interventional Cardiology Distribution
 HSMN NewsFeed - 5 Feb 2013
Twelve-Month Outcomes of Popliteal Artery Treatment with the Supera(R) Peripheral Stent System Published in JACC Cardiovascular Interventions
Devices Interventional
 HSMN NewsFeed - 4 Feb 2013
ViewRay Appoints Chris A. Raanes President and CEO
Devices Oncology Personnel
 HSMN NewsFeed - 1 Feb 2013
EDAP Submits U.S. FDA Pre-Market Approval Application for Ablatherm(R)-HIFU for Treatment of Low Risk, Localized Prostate Cancer
Devices Oncology FDA
 HSMN NewsFeed - 31 Jan 2013
IDEV Announces Results from Revascularization with Supera on Real World Patients (RESTORE) Study, Demonstrating Positive Clinical Outcomes in Significantly Diseased Patients with Long Lesions
Devices Interventional
 HSMN NewsFeed - 29 Jan 2013
Sanofi Launches Breakthrough Technology for Cardiovascular and Vascular Surgery Procedures
Devices Surgery Product Launch
 HSMN NewsFeed - 24 Jan 2013
Varian Medical Systems Receives FDA 510(k) Clearance for the Edge(TM) Radiosurgery Suite for Non-Invasive Surgical Procedures
Devices Oncology FDA
 HSMN NewsFeed - 18 Jan 2013
ThromboGenics Receives Positive CHMP Opinion for JETREA(R)
Biopharmaceuticals Ophthalmology Regulatory
 HSMN NewsFeed - 4 Jan 2013
ThromboGenics Confirms JETREA(R) US Launch Date of Monday January 14th, 2013
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 20 Dec 2012
Nanostim Announces First Series of Implants of Its Novel Leadless Cardiac Pacemaker System
Devices Cardiology Interventional Cardiology
 HSMN NewsFeed - 19 Dec 2012
Regado Biosciences, Inc. Secures $51 Million Series E Financing
Biopharmaceuticals Cardiology Venture Capital
 HSMN NewsFeed - 17 Dec 2012
Angel Medical Systems, Inc. Completes Initial Closing of $27.5 Million Financing
Devices Cardiology Monitoring Venture Capital Personnel
 HSMN NewsFeed - 7 Dec 2012
FDA Approves EVARREST(TM) Fibrin Sealant Patch
Devices Surgery FDA
 HSMN NewsFeed - 19 Nov 2012
Abacus Diagnostica Receives CE Mark for its Rapid Direct PCR Test for Toxigenic Clostridium Difficile
Diagnostics Regulatory
 HSMN NewsFeed - 8 Nov 2012
Angel(R) cPRP System Granted FDA 510(K) Clearance for Processing Blood and Bone Marrow Aspirate
Devices Regenerative Medicine Orthopaedic FDA
 HSMN NewsFeed - 1 Nov 2012
Resolve Therapeutics Raises $5.8 Million in Private Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Oct 2012
Mirna Therapeutics Secures $34.5 Million Series C Financing to Advance Oncology microRNA Pipeline into the Clinic
Biopharmaceuticals Oncology Venture Capital Personnel
 HSMN NewsFeed - 24 Oct 2012
Paradigm Spine LLC & OM HealthCare Logistics Sign Multi-Year Logistics Agreement
Devices Neurosurgery Orthopaedic Distribution
 HSMN NewsFeed - 18 Oct 2012
U.S. FDA Approves ThromboGenics' JETREA(R) (Ocriplasmin) for the Treatment of Symptomatic Vitreomacular Adhesion (VMA)
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 17 Oct 2012
Loma Vista Medical Receives FDA Clearance for its TRUE Dilatation(TM) Balloon Valvuloplasty Catheter
Devices Interventional Cardiology FDA
 HSMN NewsFeed - 15 Oct 2012
Fate Therapeutics Appoints Christian Weyer As President And Chief Executive Officer
Regenerative Medicine Personnel
 HSMN NewsFeed - 25 Sep 2012
Abbott Announces International Launch of the Absorb(TM) Bioresorbable Vascular Scaffold
Devices Interventional Cardiology
 HSMN NewsFeed - 5 Sep 2012
Intact Vascular Announces $15.5 MM Series A Financing and Names Dennis Wahr, M.D. as Chairman
Devices Interventional Venture Capital Personnel
 HSMN NewsFeed - 5 Sep 2012
CircuLite(R) Receives CE Marking Approval for SYNERGY(R) Circulatory Support System
Devices Cardiology Regulatory
 HSMN NewsFeed - 6 Aug 2012
Cytomedix Announces Medicare Coverage for Autologous PRP Gel in Chronic Wound Care
Regenerative Medicine Wound Care Reimbursement
 HSMN NewsFeed - 30 Jul 2012
23andMe Takes First Step Toward FDA Clearance
Diagnostics Personalized Medicine FDA
 HSMN NewsFeed - 26 Jul 2012
Response Biomedical Corp. Announces New Hire, Mr. Tim Shannon, as Senior Vice President, World Wide Sales & Marketing
Diagnostics Personnel
 HSMN NewsFeed - 20 Jul 2012
First Gene Therapy in Western World Receives Positive Opinion in Europe from CHMP
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 18 Jul 2012
FDA Clears First Ever Bi-directionally Retrievable Vena Cava Filter from Crux Biomedical
Devices Interventional FDA
 HSMN NewsFeed - 2 Jul 2012
NeuroSigma Receives Global Quality Control Certification
Devices Regulatory
 HSMN NewsFeed - 7 Jun 2012
Neurotech s.a. Announces European CE Mark Approval for the ADNS-300 System to Treat Refractory Epilepsy
Devices Neurology Regulatory
 HSMN NewsFeed - 6 Jun 2012
Beacon Endoscopic Announces Commercial Launch of BNX(TM) System for Use in Endoscopic Ultrasound Procedures
Devices
 HSMN NewsFeed - 29 May 2012
MAQUET Cardiovascular Announces Acquisition of the Avalon Elite(R) Bi-Caval Dual Lumen Catheter and Complimentary Vascular Access Kits from Avalon Laboratories
Devices Acquisitions
 HSMN NewsFeed - 22 May 2012
Intact Vascular, LLC Hires Scott Kraus as Vice President of Sales and Marketing
Devices Interventional Personnel
 HSMN NewsFeed - 11 May 2012
InVivo Therapeutics Adds Senior Leadership in Manufacturing and Cell Research
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 10 May 2012
Cardionovum(R) Will Launch Two Drug-Eluting Balloon (DEB) Dilatation Catheter Product Families at EuroPCR 2012
Devices Interventional Cardiology
 HSMN NewsFeed - 10 May 2012
Loma Vista Medical receives CE mark for its TRUE Dilatation(TM) Balloon Valvuloplasty Catheter
Devices Interventional Cardiology Regulatory
 HSMN NewsFeed - 7 May 2012
Ruga Corporation Expands Management Team to Advance Its Adaptive Response Therapeutics for Cancer Patients
Biopharmaceuticals Personalized Medicine Personnel
 HSMN NewsFeed - 26 Apr 2012
Epizyme Forms Strategic Partnership with Industry Leader in Epigenetic Therapies, Celgene Corporation, to Develop Personalized Therapeutics for Genetically-Defined Cancers
Biopharmaceuticals Oncology Personalized Medicine
 HSMN NewsFeed - 2 Apr 2012
AlloCure Raises $25 Million Series B Venture Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 28 Mar 2012
Kapil Dhingra, Former Head of Roche Oncology, Joins Exosome Diagnostics Board of Directors
Diagnostics Personalized Medicine Oncology Personnel
 HSMN NewsFeed - 16 Mar 2012
Sanofi to Acquire Pluromed, Inc., Expanding Its Presence in Biosurgery
Devices Surgery Mergers & Acquisitions
 HSMN NewsFeed - 14 Mar 2012
Paradigm Spine, LLC Announces Strategic Promotions and Hiring of Key Personnel to Ensure Long-Term Growth and Success
Devices Orthopaedic Neurosurgery Personnel
 HSMN NewsFeed - 8 Mar 2012
The Radiosurgery Society(TM) Completes its First Scientific Meeting as an Independent Society
Devices Oncology
 HSMN NewsFeed - 29 Feb 2012
Study of Next Step Toward Artificial Pancreas from Medtronic Meets Efficacy Endpoints
Devices Endocrinology Drug Delivery Monitoring
 HSMN NewsFeed - 13 Feb 2012
Santarus Announces Initiation of Phase IIIb Study with UCERIS in Patients with Mild or Moderate Active Ulcerative Colitis
Biopharmaceuticals Gastroenterology
 HSMN NewsFeed - 8 Feb 2012
Velomedix Closes New Financing, Strengthens Leadership Team
Devices Cardiology Neurology Venture Capital Personnel
 HSMN NewsFeed - 27 Jan 2012
LipoScience Names Timothy J. Fischer Chief Operating Officer
Diagnostics Personnel
 HSMN NewsFeed - 18 Jan 2012
Takeda Announces Strategic Measures to Achieve Efficiencies for Long-Term Growth
Biopharmaceuticals
 HSMN NewsFeed - 4 Jan 2012
Medtronic Launches First-of-Its-Kind mySentry(TM) Remote Glucose Monitor
Devices Monitoring Endocrinology
 HSMN NewsFeed - 3 Jan 2012
Cutera and IRIDEX Announce Acquisition of IRIDEX' Aesthetic Business Unit
Devices Dermatology Acquisitions
 HSMN NewsFeed - 3 Jan 2012
Cutera and IRIDEX Announce Acquisition of IRIDEX' Aesthetic Business Unit
Devices Dermatology Acquisitions
 HSMN NewsFeed - 22 Dec 2011
First Canadian Patients Treated with TriVascular Ovation™ Abdominal Stent Graft System
Devices Interventional
 HSMN NewsFeed - 12 Dec 2011
10-Year Study Demonstrates IRIDEX MicroPulse(TM) Laser Therapy Safe, Effective for Patients with Diabetic Macular Edema
Devices Ophthalmology
 HSMN NewsFeed - 1 Nov 2011
H3 Biomedicine Names Markus Warmuth Chief Executive Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 17 Oct 2011
Spinal Cord Injury Medical Leader Dr. Edward Wirth Joins InVivo Therapeutics as Chief Science Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 11 Oct 2011
iScience Interventional Receives Investment Which Accelerates Microcatheter Commercialization Activities
Devices Ophthalmology Interventional
 HSMN NewsFeed - 14 Sep 2011
AxoGen Avance(R) Nerve Graft Clinical Study Results Presented at the American Society of Surgery of the Hand
Devices Neurosurgery Regenerative Medicine
 HSMN NewsFeed - 7 Sep 2011
MiCardia Corporation Receives CE Mark for the enCorSQ Mitral Valve Repair SystemTM
Devices Cardiology Regulatory
 HSMN NewsFeed - 6 Sep 2011
ViroPharma's Buccolam(R) (Midazolam, Oromucosal Solution) Granted European Marketing Authorization for Treatment of Acute Seizures
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 31 Aug 2011
Selecta Biosciences Appoints Takashi Kei Kishimoto, Ph.D., as Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2011
Accuray Drives Growth in Radiosurgery for Early-Stage Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 27 Aug 2011
U.S. Food And Drug Administration Approves Pfizer’s XALKORI(R) (crizotinib) As First And Only Therapy Specifically For Patients With Locally Advanced Or Metastatic ALK-Positive Non-Small Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 23 Aug 2011
Spinifex Closes AU$18.25M(~US$19M) Expanded Series B Round
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 15 Aug 2011
TearScience(R) Appoints Diethart Reichardt as Senior Vice President of European Region
Devices Personnel
 HSMN NewsFeed - 8 Aug 2011
Acucela Appoints Michelle Carpenter, J.D., RAC, as Senior Vice President, Regulatory Affairs & Development Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Jul 2011
Verastem Raises $32 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 12 Jul 2011
Celsion Announces Management and Board Appointments
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 Jul 2011
St. Jude Medical Announces FDA Clearance for Industry-First Neurostimulation Lead Delivery System for the Management of Chronic Pain
Devices FDA
 HSMN NewsFeed - 12 Jul 2011
IsoRay Announces World's First Cesium-131 Treatment for Lung Cancer Using da Vinci Robotic Surgery System
Devices Oncology
 HSMN NewsFeed - 30 Jun 2011
Tenex Health Announces $5 Million in Series A Financing to Commercialize the TX1(TM) System
Devices Surgery Venture Capital
 HSMN NewsFeed - 17 May 2011
Resolve Announces Series A Financing, New Board Members
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 17 May 2011
Pfizer Announces Simultaneous Filing Of New Drug Applications For Crizotinib With U.S. Food And Drug Administration And Japanese Ministry Of Health, Labour And Welfare
Biopharmaceuticals Oncology
 HSMN NewsFeed - 12 May 2011
Verastem, Inc. Appoints Robert Forrester as Chief Operating Officer
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 12 May 2011
Varian Medical Systems Makes Equity Investment and Obtains Option to Purchase Augmenix
Devices Oncology
 HSMN NewsFeed - 9 May 2011
Medtronic and Bayer HealthCare Expand International Alliance
Devices Endocrinology
 HSMN NewsFeed - 5 May 2011
Stereotaxis and Biosense Webster Announce New Strategic Collaboration
Devices Cardiology Distribution
 HSMN NewsFeed - 28 Apr 2011
Results Promising From U.K. Clinical Trial Investigating Sonablate HIFU as a Focal Treatment for Prostate Cancer
Devices Oncology
 HSMN NewsFeed - 26 Apr 2011
BioControl Medical Launches the INOVATE-HF IDE Study of Its CardioFit(R) System for Heart Failure
Devices Cardiology
 HSMN NewsFeed - 18 Apr 2011
CoDa Therapeutics Closes $19 Million Series B Financing Round
Biopharmaceuticals Wound Care Venture Capital
 HSMN NewsFeed - 11 Apr 2011
Medtronic Launches More Accurate and Comfortable Sensor to Help Improve Glucose Control
Devices Monitoring Endocrinology
 HSMN NewsFeed - 4 Apr 2011
Cameron Health Appoints Ward Dykstra as Vice President of Global Marketing
Devices Cardiology Personnel
 HSMN NewsFeed - 7 Mar 2011
NeoStem Announces the Addition of Jason Kolbert as Vice President of Strategic Business Development
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Mar 2011
Long-Term Post-Study Follow-up and Single-Center Randomized Comparative Efficacy Study Results Demonstrate Mild(R) Safety, Efficacy
Devices Neurosurgery Orthopaedic
 HSMN NewsFeed - 2 Mar 2011
iCAD Features Image Analysis Solutions for Breast, Prostate and Colon Cancer Detection at the ECR 2011
Devices Radiology Oncology
 HSMN NewsFeed - 17 Feb 2011
InVivo Therapeutics Appoints Phil Pereira Director of Manufacturing
Devices Personnel
 HSMN NewsFeed - 16 Feb 2011
Mitomics Further Strengthens Leadership Team
Diagnostics Oncology Personnel
 HSMN NewsFeed - 2 Feb 2011
Spine Wave Announces Completion of $17.5M Financing
Devices Orthopaedic Neurosurgery Venture Capital
 HSMN NewsFeed - 27 Jan 2011
H3 Biomedicine Launches to Discover and Develop Next Generation Cancer Treatments
Biopharmaceuticals Personalized Medicine Oncology
 HSMN NewsFeed - 26 Jan 2011
Long-Term European Data Released for SUPERA(R) Stent from IDEV Technologies
Devices Interventional
 HSMN NewsFeed - 24 Jan 2011
BrainStorm Appoints Dr. Adrian Harel as Chief Operating Officer and Acting Chief Executive Officer
Regenerative Medicine Neurology Personnel
 HSMN NewsFeed - 7 Jan 2011
CardiAQ Valve Technologies (CVT) appoints Rob Michiels as Chief Executive Officer
Devices Interventional Cardiology Personnel
 HSMN NewsFeed - 4 Jan 2011
Response Biomedical Corporation Enters Into Exclusive Italian Distribution Agreement with Cremascoli & Iris, s.r.l.
Diagnostics Distribution
 HSMN NewsFeed - 17 Dec 2010
Cardiac Stem-Cell Pioneer Capricor Raises nearly $2 Million from Broadview Ventures, Private Investors
Regenerative Medicine Cardiology Venture Capital
 HSMN NewsFeed - 13 Dec 2010
Medtronic Launches CareLink Pro 3.0, the First Diabetes Management Software to Offer Advanced Decision Support
Devices Endocrinology FDA
 HSMN NewsFeed - 8 Dec 2010
Sequenta, Inc. Secures $13 Million in Series B Financing
Diagnostics Venture Capital
 HSMN NewsFeed - 17 Nov 2010
Gore Announces Availability of GORE(R) 3D Imaging System
Devices Interventional
 HSMN NewsFeed - 15 Nov 2010
NT-proBNP Guided Therapy Keeps Heart Failure Patients out of the Hospital Through a Reduction in Cardiovascular Events
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 15 Nov 2010
Cardium Reports on Presentation at American Heart Association Meeting Relating to Gene Delivery to the Heart and Generx Clinical Development
Biopharmaceuticals Devices Interventional Cardiology
 HSMN NewsFeed - 3 Nov 2010
IDEV Technologies Announces FDA 510(k) Clearance for SUPERA VERITAS
Devices Interventional FDA
 HSMN NewsFeed - 28 Oct 2010
Sanofi-Aventis Completes $10 Million Equity Investment in Regulus Therapeutics
Biopharmaceuticals
 HSMN NewsFeed - 27 Oct 2010
Calypso Medical Initiates First Clinical Study Using Real-Time Tracking During Lung Cancer Radiotherapy
Devices Oncology
 HSMN NewsFeed - 26 Oct 2010
Response Biomedical Corporation Announces the Resignation of Chief Operating Officer
Diagnostics Personnel
 HSMN NewsFeed - 25 Oct 2010
Kadmon Pharmaceuticals Acquires Three Rivers Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 15 Oct 2010
GI Dynamics Receives European CE Mark Approval for 12 Months of EndoBarrier(TM) Treatment of Type 2 Diabetes and Obesity; Announces U.K. Launch
Devices Gastroenterology Endocrinology Regulatory
 HSMN NewsFeed - 14 Oct 2010
Paradigm Medical Management Introduces Amputation Prevention Centers of America
Devices Wound Care
 HSMN NewsFeed - 14 Oct 2010
NinePoint Medical Completes $33 Million Series A Financing to Develop Innovative Broad-Based Medical Platform for in vivo Pathology Devices
Devices Diagnostics Venture Capital
 HSMN NewsFeed - 13 Oct 2010
IsoRay's Revolutionary Internal Radiation Therapy for Lung Cancers is Focus of National Study
Devices Oncology
 HSMN NewsFeed - 21 Sep 2010
Susan Hertzberg Named CEO of Boston Heart Lab; Company Closes $10 Million in Series C Financing with Bain Capital Ventures as Lead Investor
Diagnostics Personnel Venture Capital
 HSMN NewsFeed - 20 Sep 2010
Corindus Announces Results of First-in-Human Clinical Study of CorPath(R) 200 System
Devices Interventional Cardiology
 HSMN NewsFeed - 13 Sep 2010
Response Biomedical Announces Strategic Realignment of Resources
Diagnostics
 HSMN NewsFeed - 8 Sep 2010
Zyngenia, Inc. Raises $15 Million in Series A Extension Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Sep 2010
GI Dynamics Announces New Data Showing Significant Weight Loss, Cardiovascular and Metabolic Improvements Following 12 Months of EndoBarrier Treatment
Devices Gastroenterology
 HSMN NewsFeed - 29 Jul 2010
Abraxis BioScience and Specialised Therapeutics Announce Approval to Market ABRAXANE for Metastatic Breast Cancer in New Zealand
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 23 Jul 2010
ABRAXANE(R) Approved for Marketing in Japan for Breast Cancer
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 21 Jul 2010
GE Launches Study to Improve Diagnosis of Early Stage Colon Cancer
Diagnostics Oncology
 HSMN NewsFeed - 14 Jul 2010
ConvaTec Supports Development of Guidelines for Appropriate Use of Negative Pressure Wound Therapy in Spectrum of Wound Healing
Devices Wound Care
 HSMN NewsFeed - 14 Jul 2010
Former Pfizer Senior Vice President Named CEO of Berlin Pharmaceutical Industry in a Partnership to Diversify and Expand Company Business in Asia
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Jul 2010
iPierian Closes $22 Million Series B Financing Led By Google Ventures
Biopharmaceuticals Regenerative Medicine Venture Capital
Return to NewsFeed  

 Additional items found! 244

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 244 additional stories matching:
Paradigm
(Password required)
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!